Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Economic and Financial Impacts of Cancer

18 ta ish

  1. Cancer treatment and survivorship statistics, 2019

    Kimberly D. Miller, Letícia Nogueira, Angela B. Mariotto +6

    MaqolaOchiq kirishCancer survivorship and careCA A Cancer Journal for Clinicians20194 iqtibos
    ABI

  2. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review

    Nathan Brand, Liang G. Qu, Ann Chao +1

    Sharh maqolaOchiq kirishGlobal Cancer Incidence and ScreeningThe Oncologist20192 iqtibos
    ABI

  3. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases

    Benjamin O. Anderson, André Ilbawi, Elena Fidarova +4

    MaqolaGlobal Cancer Incidence and ScreeningThe Lancet Oncology20212 iqtibos
    ABI

  4. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Jonathan Kocarnik, Kelly Compton, Frances Dean +97

    Sharh maqolaOchiq kirishCOVID-19 and healthcare impactsJAMA Oncology20211 iqtibos
    ABI

  5. Pharmacoeconomics and the Patients’ Compliance as an Essential part of Successful therapy of iron Deficiency Anemia.

    Khodjieva Gulirano Sayfullaevna

    MaqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeIndonesian Journal of Innovation Studies20221 iqtibos
    ABI

  6. Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience

    Sara Stulac, Agnès Binagwaho, Neo Tapela +13

    Sharh maqolaGlobal Health and SurgeryThe Lancet Oncology20151 iqtibos
    ABI

  7. Core elements of national cancer control plans: a tool to support plan development and review

    Andrew Oar, Fábio Ynoe de Moraes, Yannick Romero +2

    Sharh maqolaGlobal Cancer Incidence and ScreeningThe Lancet Oncology20191 iqtibos
    ABI

  8. Survivorship objectives in comprehensive cancer control plans: a systematic review

    Michelle Mollica, Angela Falisi, Ann M. Geiger +5

    Sharh maqolaOchiq kirishCancer survivorship and careJournal of Cancer Survivorship20201 iqtibos
    ABI

  9. Enhancing global access to cancer medicines

    Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

    Sharh maqolaOchiq kirishEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos
    ABI

  10. Shortages and price variability of essential cytotoxic medicines for treating children with cancers

    Yehoda M. Martei, Kotoji Iwamoto, Ronald D. Barr +2

    MaqolaOchiq kirishPharmaceutical Economics and PolicyBMJ Global Health20201 iqtibos
    ABI

  11. Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer Hospital

    Yasuyoshi Sato, Yu Fujiwara, Naoki Fukuda +4

    BoshqaOchiq kirishCOVID-19 and healthcare impactsCancer Cell20211 iqtibos
    ABI

  12. A Status Report on the Health Care Sector in France

    N. Lalitha, Samira Guennif

    MaqolaPharmaceutical Economics and PolicyJournal of Health Management20080 iqtibos
    ABI

  13. Malignant tumors morbidity and ecological situation in some regions of Republic of Uzbekistan.

    Abdulla Nusratillaevich Abdihakimov, B. B. Niyazmetov, А. Yu. Madaminov +2

    MaqolaOchiq kirishNutrition, Genetics, and DiseaseEkologiya cheloveka (Human Ecology)20120 iqtibos
    ABI

  14. PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    MaqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeValue in Health20190 iqtibos
    ABI

  15. Review of Pharmacoeconomic Studies in Russian Cancer Research: An Outside View

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    Sharh maqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeValue in Health Regional Issues20190 iqtibos
    ABI

  16. МЕТОД УПРАВЛЕНИЯ ОНКОЭПИДЕМИОЛОГИЧЕСКОЙ СИТУАЦИЕЙ С ПОМОЩЬЮ ЦИФРОВОГО ПРОГРАММНОГО ПРОДУКТА

    N. M. Alimkulov, M. Kh. Khudaiberdiev

    MaqolaDigital Media and Visual ArtJournal of science and innovative development20230 iqtibos
    ABI

  17. The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.

    Kamila Izrailbekova, Sergey Kamishov, Sunnatilla Saydullaev +4

    MaqolaOchiq kirishPARP inhibition in cancer therapyJournal of Clinical Oncology20240 iqtibos
    ABI

  18. Comparative Analysis of Treatment Standards for Acute Lymphoblastic Leukaemia

    A. Reinout, Umarova Sh.Z, Pulatova N.S

    MaqolaOchiq kirishAcute Lymphoblastic Leukemia researchJournal of Pharmacoeconomics and Pharmaceutical Management20250 iqtibos
    ABI